DAB2IP and lung carcinoma: The impaired expression of these markers might generate the abnormal cell proliferation in the area of metaplastic epithelium, suggesting a potential involvement of EZH2/H3K27me3/DAB2IP pathway in the progression of inflammatory diseases of the airways toward lung cancer.